Atlas Trials

Steroid-Refractory Acute Graft-Versus-Host Disease

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Steroid-Refractory Acute Graft-Versus-Host Disease

RecordFirmDate
A Study to Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002) (NCT04934670)Xenikos2022-06-16
Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy (NCT04629833)medac GmbH2021-08-16
T-Guard as Treatment for Steroid Refractory Acute GVHD (BMT CTN 1802) (NCT04128319)Xenikos2019-11-21
Neihulizumab (ALTB-168) in Patients With Steroid-refractory Acute Graft-versus-host Disease or Treatment-refractory Acute Graft-versus-host Disease (NCT03327857)AltruBio Inc.2018-05-31
Methoxsalen and Extracorporeal Photopheresis (ECP) for the Treatment of Pediatric Participants With Steroid Refractory Acute Graft Versus Host Disease (NCT02524847)Therakos, Inc., a Mallinckrodt Company2016-01-20
Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT) (NCT03172455)Impatients N.V. trading as myTomorrows

Track Steroid-Refractory Acute Graft-Versus-Host Disease automatically

Every clearance here is in the API, with alerts when new ones post.